Fred Hirsch, MD, PhD from the University of Colorado, Denver, CO speaks about the collaboration between IASLC, CAP and AMP to develop guidelines for molecular testing in lung cancer. The field of molecular testing is rapidly evolving and therefore guidelines need to be developed and updated continuously. This interview was recorded at the annual meeting of the European Lung Cancer Conference (ELCC) 2017, Geneva, Switzerland.